Preclina is a non-clinical CRO with fully-integrated drug discovery platform specialized in autoimmune disorders and inflammatory conditions, based on our core skills in immunology and extensive expertise in patient-derived cells and animal models recapitulating these disorders.

As a CRO that delivers extraordinary values to biotech companies, pharmaceutical companies, and researchers all around the world, we collaborate with our clients to successfully develop new drugs and diagnostic/therapeutic technologies.